Literature DB >> 15048746

Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin.

D Elias1, M Pocard, L Sideris, C Edè, M Ducreux, V Boige, P Lasser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15048746     DOI： 10.1002/bjs.4399

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  10 in total

Review 1.  Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  César P Ramírez Plaza; Manuel A Cobo Dols; Alberto Gómez Portilla; Agustín de la Fuente Perucho
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study.

Authors:  Franck Zenasni; Marion Botella; Dominique Elias; Sarah Dauchy; Valérie Boige; David Malka; Michel Ducreux; Jean-Pierre Pignon; Diane Goéré; Marc Pocard
Journal:  Support Care Cancer       Date:  2009-02-06       Impact factor: 3.603

Review 4.  Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7.

Authors:  Peter Cashin; Paul H Sugarbaker
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  Treatment recommendations for metastatic colorectal cancer.

Authors:  Enrique Aranda; Albert Abad; Alfredo Carrato; Andrés Cervantes; Jesús García-Foncillas; Pilar García Alfonso; Rocío García Carbonero; Auxiliadora Gómez España; Josep M Tabernero; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

6.  Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.

Authors:  Lucas Sideris; Andrew Mitchell; Pierre Drolet; Guy Leblanc; Yves E Leclerc; Pierre Dubé
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

7.  Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.

Authors:  Reza Kianmanesh; Stefano Scaringi; Jean-Marc Sabate; Benjamin Castel; Nathalie Pons-Kerjean; Benoit Coffin; Jean-Marie Hay; Yves Flamant; Simon Msika
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 8.  Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature.

Authors:  Amandine Pinto; Marc Pocard
Journal:  Pleura Peritoneum       Date:  2019-05-29

9.  10 ns PEFs induce a histological response linked to cell death and cytotoxic T-lymphocytes in an immunocompetent mouse model of peritoneal metastasis.

Authors:  A Taibi; M-L Perrin; J Albouys; J Jacques; C Yardin; S Durand-Fontanier; S M Bardet
Journal:  Clin Transl Oncol       Date:  2021-03-07       Impact factor: 3.405

Review 10.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.

Authors:  Chao-Qun Huang; Yao Min; Shu-Yi Wang; Xiao-Jun Yang; Yang Liu; Bin Xiong; Yutaka Yonemura; Yan Li
Journal:  Oncotarget       Date:  2017-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.